Clinician's Roundtable

Host: Leslie P. Lundt, MD Guest: Jorge Herrera, MD Chronic hepatitis B (HBV) is a potentially serious disease that can lead to cirrhosis, liver failure, and hepatocellular carcinoma. Several effective pharmacologic therapies are available for use in treatment, however who and how to treat can be complicated and confusing. What is a clinician to do? Hepatologist Dr. Jorge Herrera joins host Dr. Leslie Lundt to discuss these issues.

Host: Leslie P. Lundt, MD Guest: Jorge Herrera, MD The future of hepatitis C treatment looks bright -- most likely with the new oral, protease and polymerase inhibitors currently in development. Although these agents represent an exciting phase in the development of effective hepatitis C therapy, they are still a few years away from being recommended for routine clinical use. What can we look forward to? Expert hepatologist Dr. Jorge Herrera joins host Dr. Leslie Lundt to discuss the latest research in Hepatitis C treatments.

Host: Leslie P. Lundt, MD Guest: Jorge Herrera, MD Since 2001, combination therapy with pegylated interferon with ribavirin is considered the standard of care in hepatitis C treatment. In clinical trials, 50 to 60 percent of patients treated with combination therapy achieved a sustained virologic response, or SVR, meaning the virus is undetectable in their blood. Dr. Jorge Herrera joins host Dr. Leslie Lundt to discuss the state of the art for treatment of Hepatitis C.

Host: Leslie P. Lundt, MD Guest: Jorge Herrera, MD Hepatitis C is often known as a “silent killer” since many people who are infected do not realize they have the disease. With few symptoms associated with hepatitis C, they may be infected for decades without realizing it. Host Dr. Leslie Lundt welcomes Dr. Jorge Herrera to discuss who, why and what to order when looking for Hepatitis C.

Host: Paul Raeburn Guest: Sen. Hillary Clinton, JD Join us for another in our special presidential editions of the Washington Health Report. We hear from Sen. Hillary Clinton about the details of her sweeping healthcare reform proposal. She explains the plan in depth in her own words.

Host: Susan Dolan, RN, JD Guest: Jim Conway, MD, MS Join Jim Conway, Chairman of the Partnership for Healthcare Excellence and Senior Vice President of the Institute of Healthcare Improvement in Cambridge, Massachusetts, to discuss how hospital boards of directors can make a difference.

Host: Susan Dolan, RN, JD Guest: Jim Conway, MD, MS Join Jim Conway, Chairman of the Partnership for Healthcare Excellence, as he discusses how the Partnership is mobilizing consumers to become advocates for change, educating people about the variations of healthcare and encouraging patients to become more involved.

Host: Susan Dolan, RN, JD Guest: Lila Ivey Join Lila Ivey, Director of the Community Outreach Department for the Hospice of Marion County in Ocala, Florida, discuss why The Tuscany House won Healthcare Design's Architectural Showcase.

Host: Larry Kaskel, MD Guest: Richard Valicenti, MD What are the reasons a patient should have surgery vs. radiation therapy when trying to cure prostate cancer? When are both treatments recommended? Join oncology radiation specialist Dr. Rick Valicenti speak with host Dr. Larry Kaskel about the most promising treatments for prostate cancer patients.

Host: Larry Kaskel, MD Guest: Richard Valicenti, MD Join Host Dr. Larry Kaskel with Dr. Richard Valicenti, nationally known for radiotherapeutic managment of prostate cancer, talking about a new approach to Brachytherapy and 3D Conformal Radiation Therapy.